Clinical trial Recruiting at 1 site Observational Ages 19 and up

Evaluating the effectiveness and safety of Xience Skypoint stents in treating coronary artery disease

Official title: a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease

Run by Asan Medical Center · NCT05981911 · Data updated 2026-11-12

This study is testing how well and safely XIENCE Skypoint stents work for people with coronary artery disease compared to other similar stents in everyday medical practice.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment2000 (estimated)
SponsorAsan Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedDecember 14, 2023
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedJanuary 2, 2026
Trial IDNCT05981911 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 19 and older who are receiving Xience Skypoint stents.

Probably not a fit

Patients with terminal illnesses or those experiencing cardiogenic shock may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess how effective and safe XIENCE Skypoint stents are when used in routine clinical practice, compared to other drug-eluting stents. It involves observing patients who are receiving these stents and collecting data on their outcomes. The study will focus on real-world applications rather than controlled environments, providing insights into the stents' performance in everyday clinical settings.

Why it matters

Potential benefit: If successful, this study could provide valuable information on the effectiveness and safety of Xience Skypoint stents, potentially leading to improved treatment options for patients with coronary artery disease.

How similar studies have gone: Other studies evaluating the effectiveness of drug-eluting stents have shown promising results, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients ≥ 19 years old
2. Patients receiving Xience-Skypoint™ stents.
3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria:

1. Patients with a mixture of other DESs
2. Terminal illness with life expectancy \<1 year
3. Patients with cardiogenic shock

Where it's running

  • Asan Medical Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.